Page 1 of 159
WEEK 1 - 4 MIDTERM: NR566 / NR-566 (LATEST 2025 /
2026 UPDATES STUDY BUNDLE WITH COMPLETE
SOLUTIONS) ADVANCED PHARMACOLOGY FOR CARE
OF THE FAMILY | QUESTIONS AND VERIFIED
ANSWERS | 100% CORRECT | GRADE A -
CHAMBERLAIN
Albuterol .....ANSWER.....-increases levels of digoxin
-safe if children
-first line therapy
Etidronate (Didronel) .....ANSWER.....Bisphosphonates
-90 day half life
-preg cat B
reduces bone reabsorption
,Page 2 of 159
TX: low bone density, d/t cystic fibrosis, pagets disease (monitor
xrays and labs), heterotropic ossification, hip replacement, spinal
cord injury
CI: entercolitis
Alendeonate (fosamax) .....ANSWER.....Biphosphonates
-10 yr. half life
( $cheapest)
TX: osteoporosis men, postmenopausal women, gluccorticoids
induced, pagets diseae
bioavailability of biphosphonates .....ANSWER.....histamine 2
blocking, ranitadine agents double ALENDRONATE
TILUDRONATE decrease 50 % by aspirin and is increased by
INDOMENTHACIN *consider each nsaid individually
Anastozole, letroxole, exemestane .....ANSWER.....aromatase
inhibitors
,Page 3 of 159
*hormone therapy to tx hormone receptor positive breast cancer.
AE: vertigo, insomnia, sleepiness, confusion, LIFE THREATENING
BLOOD CLOTTING, LOSS BONE MASS,
*take Ca+ vit D supplementation
*measure bone density
GH (somatotropin) .....ANSWER.....*used in children with GH
deficiency treats hypoglycemia
Biophosphanates pt education .....ANSWER.....*empty stomach 8
oz water
avoid anitacids/ alcohol
ETIDRONATE increase in fx with pagets disease monitor labs and
xrays
drugs associated with bone loss that should be monitored
.....ANSWER.....aromatase inhibitors, thyroid hormones,
gluccocorticoid, PPI, SSRI
, Page 4 of 159
Antidiabetic mediations to avoid in elderly
.....ANSWER.....Sulfonylureas -hypoglycemia
Glimpride
Glyburide- most likely to cause hypo
metformin *renal insuffiency HF
Alpha-glycosidase inhibitors- not well tolerated
Screening of Type 2 DM .....ANSWER.....>45 yrs old BMI >25
*test yearly
>45 yrs old BMI WNL *q 3 yrs
<45 yrs old VMI >25* test more frequent.
Lispro, Aspart, Glulisine .....ANSWER.....rapid acting insulin
15 min peak 1 hr duration
Regular insulin
WEEK 1 - 4 MIDTERM: NR566 / NR-566 (LATEST 2025 /
2026 UPDATES STUDY BUNDLE WITH COMPLETE
SOLUTIONS) ADVANCED PHARMACOLOGY FOR CARE
OF THE FAMILY | QUESTIONS AND VERIFIED
ANSWERS | 100% CORRECT | GRADE A -
CHAMBERLAIN
Albuterol .....ANSWER.....-increases levels of digoxin
-safe if children
-first line therapy
Etidronate (Didronel) .....ANSWER.....Bisphosphonates
-90 day half life
-preg cat B
reduces bone reabsorption
,Page 2 of 159
TX: low bone density, d/t cystic fibrosis, pagets disease (monitor
xrays and labs), heterotropic ossification, hip replacement, spinal
cord injury
CI: entercolitis
Alendeonate (fosamax) .....ANSWER.....Biphosphonates
-10 yr. half life
( $cheapest)
TX: osteoporosis men, postmenopausal women, gluccorticoids
induced, pagets diseae
bioavailability of biphosphonates .....ANSWER.....histamine 2
blocking, ranitadine agents double ALENDRONATE
TILUDRONATE decrease 50 % by aspirin and is increased by
INDOMENTHACIN *consider each nsaid individually
Anastozole, letroxole, exemestane .....ANSWER.....aromatase
inhibitors
,Page 3 of 159
*hormone therapy to tx hormone receptor positive breast cancer.
AE: vertigo, insomnia, sleepiness, confusion, LIFE THREATENING
BLOOD CLOTTING, LOSS BONE MASS,
*take Ca+ vit D supplementation
*measure bone density
GH (somatotropin) .....ANSWER.....*used in children with GH
deficiency treats hypoglycemia
Biophosphanates pt education .....ANSWER.....*empty stomach 8
oz water
avoid anitacids/ alcohol
ETIDRONATE increase in fx with pagets disease monitor labs and
xrays
drugs associated with bone loss that should be monitored
.....ANSWER.....aromatase inhibitors, thyroid hormones,
gluccocorticoid, PPI, SSRI
, Page 4 of 159
Antidiabetic mediations to avoid in elderly
.....ANSWER.....Sulfonylureas -hypoglycemia
Glimpride
Glyburide- most likely to cause hypo
metformin *renal insuffiency HF
Alpha-glycosidase inhibitors- not well tolerated
Screening of Type 2 DM .....ANSWER.....>45 yrs old BMI >25
*test yearly
>45 yrs old BMI WNL *q 3 yrs
<45 yrs old VMI >25* test more frequent.
Lispro, Aspart, Glulisine .....ANSWER.....rapid acting insulin
15 min peak 1 hr duration
Regular insulin
